Retraction: "Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial"
- PMID: 40739462
- PMCID: PMC12317233
- DOI: 10.1177/17534666251362671
Retraction: "Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial"
Retraction of
-
Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221099729. doi: 10.1177/17534666221099729. Ther Adv Respir Dis. 2022. Retraction in: Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251362671. doi: 10.1177/17534666251362671. PMID: 35657073 Free PMC article. Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
